93703-24-3 (8-溴-3-甲基黄嘌呤,8-bromo-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione)

CAS号:
93703-24-3
中文名称:
8-溴-3-甲基黄嘌呤
英文名称:
8-bromo-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
分子式:
C6H5BrN4O2
分子量:
245.033499479294

8-溴-3-甲基黄嘌呤(93703-24-3)名称与标识符

名称

中文别名:
8-溴-3-甲基黄嘌呤;8-溴-3-甲基-3,7-二氢嘌呤-2,6-二酮;8-溴-3-甲基-3,7-二氢-嘌呤-2,6-二酮; 8-溴-3-甲基黄嘌呤;8-溴-3-甲基-1H-嘌呤-2,6(3H,7H)-二酮;8溴3甲基黄嘌呤;8-溴-3-甲基黄嘌呤,8-Bromo-3-methylxanthine;B5:8-溴-3-甲基黄嘌呤;利拉利汀中间体;利拉利汀中间体3;利拉列汀中间体4;8-溴-3-甲基黄嘌呤,利拉利汀中间体;
英文别名:
8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione;8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione;8-Bromo-3-methylxanthine;1H-Purine-2,6-dione,8-bromo-3,9-dihydro-3-methyl-;8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione;8-BroMo-3-Methyl-3,7-dihydro-purine-2,6-dione;8-Bromo-3-methyl-3,9-dihydro-purine-2,6-dione;8-Bromo-3-methyl-xanthine;8-bromo-3-methyl-7H-purine-2,6-dione;1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl- (9CI);8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione (ACI);3-Methyl-8-bromoxanthine;8-bromo-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione;8-bromo-3-methyl xanthine;J-519386;8-bromo-6-hydroxy-3-methyl-3,7-dihydro-2H-purin-2-one;SCHEMBL1241218;BBL012668;MFCD00462528;EN300-134139;DB-079665;STK656575;CS-W019625;8-bromo-3-methylpurine-2,6-diol;SCHEMBL15924314;BCP12331;Oprea1_287813;Oprea1_865455;SR-01000506601;8-bromo3-Methyl-xanthine;1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-;G10016;F0381-3715;F0373-0001;3-methyl-8-bromo-xanthine;8-bromo-6-hydroxy-3-methyl-1H-purin-2-one;DTXSID50364285;AC-26251;C6H5BrN4O2;AKOS005587316;3-Methyl-8-bromoxanthine; 8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione; 8-Bromo-3-methylxanthine; Linagliptin 8-Bromo Impurity;HMS1649I20;QTEQVEJOXGBDGI-UHFFFAOYSA-N;8-bromo-3-methyl-1H-purine-2,6(3H,9H)-dione;SR-01000506601-1;SY038324;B4134;8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione;STK803300;93703-24-3;8-bromo-3-methyl-1H-purine-2,6(3H,7H)- dione;AS-19142;MLS-0463078.0001;AKOS000267178;

标识符

MDL:
MFCD00462528
InChIKey:
QTEQVEJOXGBDGI-UHFFFAOYSA-N
Inchi:
1S/C6H5BrN4O2/c1-11-3-2(8-5(7)9-3)4(12)10-6(11)13/h1H3,(H,8,9)(H,10,12,13)
SMILES:
O=C1C2=C(N=C(N2)Br)N(C)C(=O)N1

8-溴-3-甲基黄嘌呤(93703-24-3)物化性质

实验特性

  • LogP : -0.28760
  • PSA : 83.54000
  • 熔点 : 300°C(lit.)
  • 密度 : 1.974

计算特性

  • 精确分子量 : 243.96000
  • 氢键供体数量 : 2
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 0
  • 同位素质量 : 243.96
  • 重原子数量 : 13
  • 复杂度 : 271
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 0.3
  • 拓扑分子极性表面积 : 78.1A^2

8-溴-3-甲基黄嘌呤(93703-24-3)海关数据

海关编码:
2933990090
海关数据:

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

8-溴-3-甲基黄嘌呤(93703-24-3)推荐厂家 更多厂家(155)

公司名称手机号/电话联系人QQ微信询单
湖北齐飞医药化工有限公司 18071128683
027-59322506
汪经理18071128683(微信同号) 1438280077
询单
江苏润丰合成科技有限公司 18662931390
0513-66017679
蔡经理 507167383 询单
济南立德医药技术有限公司 15550407051
053-168654990
陈先生 3003132598 询单
江苏倍达医药科技有限公司 18994340901
0512-63009836
贺慧 540534176 询单
苏州市森菲达化工有限公司 13862111431
0512-66387035
王婷婷询单
湖北达豪化工有限公司 13986246535刘紫莹 1400878822
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
江苏雷恩环保科技有限公司 18662920632
0513-66017275
费小姐 3485543679 询单
江西伯业医药科技有限公司 15377010747
027-81625225
李端慧 3266171690
询单
湖北摆渡化学有限公司 13517219350
13517219350
彭星 1400878899
询单

8-溴-3-甲基黄嘌呤(93703-24-3)合成路线

合成路线:1 步
反应条件:
参考文献:
Preparation method of linagliptin intermediate 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Substituted xanthines as TRPC5 ion channel inhibitor and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis
Konduri, Srihari ; Prashanth, Jyothi; Krishna, Vagolu Siva; Sriram, Dharmarajan; Behera, J. N.; et al, Bioorganic & Medicinal Chemistry Letters, 2020, 30(22),
合成路线:1 步
反应条件:
参考文献:
Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling
Feng, Guo-shuai; Zhu, Cui-ge; Li, Zhuo-ming; Wang, Pan-xia; Huang, Yi; et al, Acta Pharmacologica Sinica, 2017, 38(5), 638-650
合成路线:1 步
反应条件:
参考文献:
Preparation of linagliptin intermediate pyrimidine derivative
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents
Li, Gang; Huan, Yi; Yuan, Baokun; Wang, Jin; Jiang, Qian; et al, European Journal of Medicinal Chemistry, 2016, 124, 103-116
合成路线:1 步
反应条件:
参考文献:
An improved process for the preparation of Linagliptin
, India, , ,
合成路线:1 步
反应条件:
参考文献:
Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold
Jansen, Koen; De Winter, Hans; Heirbaut, Leen; Cheng, Jonathan D.; Joossens, Jurgen; et al, MedChemComm, 2014, 5(11), 1700-1707
合成路线:1 步
反应条件:
参考文献:
Preparation of xanthines and related compounds for inhibiting interleukin-12 intracellular signaling
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of xanthine derivatives and analogs as cell signaling inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Process for preparation of xanthine compound and application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of Linagliptin
Liu, Xiangsheng; Zhang, Yi; Zhang, Jiquan; Wang, Jianta; Tang, Lei, Zhongguo Yiyao Gongye Zazhi, 2016, 47(1), 4-7
合成路线:1 步
反应条件:
参考文献:
Preparation of xanthine derivatives as inhibitors of tryptophan hydroxylases, useful in treatment of diseases alone and in pharmaceutical compositions
, European Patent Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Structure-Based Optimization of Potent and Selective Inhibitors of the Tyrosine Kinase Erythropoietin Producing Human Hepatocellular Carcinoma Receptor B4 (EphB4)
Lafleur, Karine; Huang, Danzhi; Zhou, Ting; Caflisch, Amedeo; Nevado, Cristina, Journal of Medicinal Chemistry, 2009, 52(20), 6433-6446
合成路线:1 步
反应条件:
参考文献:
Substituted xanthine compound, preparation and application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Crystalline form of 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione intermediates
Anonymous, IP.com Journal, 2014, 14, 1-7
合成路线:1 步
反应条件:
参考文献:
Preparation of purine derivatives as inhibitors of the enzyme DPP-IV
, World Intellectual Property Organization, , ,

8-溴-3-甲基黄嘌呤(93703-24-3)谱图信息

1H NMR300 MHzDMSO
1H NMR
13C NMR
13C NMR

8-溴-3-甲基黄嘌呤(93703-24-3)参考资料

Reaxys RN:
4691271
Beilstein:
B152927
PubChem CID: